FI823624L - Foerfarande foer framstaellning av ett preparat foer behandling av urinvaegsinfektioner - Google Patents

Foerfarande foer framstaellning av ett preparat foer behandling av urinvaegsinfektioner

Info

Publication number
FI823624L
FI823624L FI823624A FI823624A FI823624L FI 823624 L FI823624 L FI 823624L FI 823624 A FI823624 A FI 823624A FI 823624 A FI823624 A FI 823624A FI 823624 L FI823624 L FI 823624L
Authority
FI
Finland
Prior art keywords
foer
urinvaegsinfektioner
preparat
ett
behandling
Prior art date
Application number
FI823624A
Other languages
English (en)
Finnish (fi)
Other versions
FI823624A0 (fi
Inventor
William L Davies
Original Assignee
Norwich Eaton Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norwich Eaton Pharma filed Critical Norwich Eaton Pharma
Publication of FI823624A0 publication Critical patent/FI823624A0/fi
Publication of FI823624L publication Critical patent/FI823624L/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FI823624A 1981-10-26 1982-10-25 Foerfarande foer framstaellning av ett preparat foer behandling av urinvaegsinfektioner FI823624L (fi)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/314,656 US4370313A (en) 1981-10-26 1981-10-26 Nitrofurantoin dosage form

Publications (2)

Publication Number Publication Date
FI823624A0 FI823624A0 (fi) 1982-10-25
FI823624L true FI823624L (fi) 1983-04-27

Family

ID=23220880

Family Applications (1)

Application Number Title Priority Date Filing Date
FI823624A FI823624L (fi) 1981-10-26 1982-10-25 Foerfarande foer framstaellning av ett preparat foer behandling av urinvaegsinfektioner

Country Status (18)

Country Link
US (1) US4370313A (pt)
EP (1) EP0078079B1 (pt)
JP (1) JPS5883618A (pt)
AT (1) AT387142B (pt)
AU (1) AU557553B2 (pt)
CA (1) CA1181695A (pt)
DE (1) DE3276522D1 (pt)
DK (1) DK472182A (pt)
ES (1) ES516815A0 (pt)
FI (1) FI823624L (pt)
GR (1) GR77686B (pt)
IE (1) IE54083B1 (pt)
IL (1) IL66961A (pt)
NO (1) NO157805C (pt)
NZ (1) NZ202140A (pt)
PH (1) PH17286A (pt)
PT (1) PT75731B (pt)
ZA (1) ZA827457B (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4639458A (en) * 1985-01-22 1987-01-27 Merck & Co., Inc. Tablet and formulation
US4874614A (en) * 1985-03-25 1989-10-17 Abbott Laboratories Pharmaceutical tableting method
US4863741A (en) * 1985-03-25 1989-09-05 Abbott Laboratories Tablet composition for drug combinations
US5560909A (en) * 1986-06-03 1996-10-01 Dowelanco Insecticidal compositions and process for preparation thereof
US4798725A (en) * 1986-06-16 1989-01-17 Norwich Eaton Pharmaceuticals, Inc. Sustained release capsule
US4772473A (en) * 1986-06-16 1988-09-20 Norwich Eaton Pharmaceuticals, Inc. Nitrofurantoin dosage form
US4822629A (en) * 1986-12-12 1989-04-18 Norwich Eaton Pharmaceuticals, Inc. Azumolene dosage form
US4938966A (en) * 1988-11-30 1990-07-03 Riker Laboratories, Inc. Controlled release flecainide acetate formulation
US5178880A (en) * 1989-07-25 1993-01-12 Norwich Eaton Pharmaceuticals, Inc. Liquid suspensions of nitrofurantoin
US5332832A (en) * 1989-07-26 1994-07-26 Procter & Gamble Pharmaceuticals, Inc. Nitrofurantoin crystals
EP1064938A1 (en) * 1999-06-28 2001-01-03 Sanofi-Synthelabo Pharmaceutical dosage forms for controlled release producing at least a timed pulse
DE19959419A1 (de) * 1999-12-09 2001-06-21 Ratiopharm Gmbh Stabile galenische Zubereitungen umfassend ein Benzimidazol und Verfahren zu ihrer Herstellung
DE10031043A1 (de) * 2000-06-26 2002-02-14 Bayer Ag Retardzubereitungen von Chinolonantibiotika und Verfahren zu ihrer Herstellung
US20060002997A1 (en) * 2002-08-23 2006-01-05 Puneet Shamar Nitrofurantoin controlled release dosage form
US20050202079A1 (en) * 2004-03-15 2005-09-15 Mylan Pharmaceuticals Inc. Novel orally administrable formulation of nitrofurantoin and a method for preparing said formulation
CN102695554A (zh) * 2009-11-08 2012-09-26 梅达雷公司 用于形成空心纤维和空心纤维束的方法
CN108553443B (zh) * 2018-04-24 2020-09-01 江苏四环生物制药有限公司 一种呋喃妥因肠溶片的制备方法
IT201900000897A1 (it) * 2019-01-22 2020-07-22 Phf S A Formulazione a rilascio prolungato a permanenza gastrica a base di nitrofurantoina

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE644759C (de) * 1932-11-23 1937-05-12 I G Farbenindustrie Akt Ges Verfahren zum UEberziehen von Arzneiformen mit gegen Magensaeure und Magenfermente bestaendigen UEberzuegen
BE593353A (pt) * 1959-02-18
US4060598A (en) * 1967-06-28 1977-11-29 Boehringer Mannheim G.M.B.H. Tablets coated with aqueous resin dispersions
US3577512A (en) * 1968-10-11 1971-05-04 Nat Patent Dev Corp Sustained release tablets
DE1931910B2 (de) * 1969-06-24 1974-11-28 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur Herstellung fester, steuerbar resorbierbarer Arzneimittelzubereitungen schwer löslicher Wirkstoffe
DE2031871C3 (de) * 1970-06-27 1974-06-27 Roehm Gmbh, 6100 Darmstadt Überzugsmasse für Arzneiformen
US3641237A (en) * 1970-09-30 1972-02-08 Nat Patent Dev Corp Zero order release constant elution rate drug dosage
GB1403584A (en) * 1972-05-19 1975-08-28 Beecham Group Ltd Control medicaments
US3954959A (en) * 1973-03-28 1976-05-04 A/S Alfred Benzon Oral drug preparations
US4177256A (en) * 1973-04-25 1979-12-04 Alza Corporation Osmotic bursting drug delivery device
DE2336218C3 (de) * 1973-07-17 1985-11-14 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Orale Arzneiform
US3926188A (en) * 1974-11-14 1975-12-16 Alza Corp Laminated drug dispenser
SE418247B (sv) * 1975-11-17 1981-05-18 Haessle Ab Sett att framstella kroppar med reglerad frigoring av en aktiv komponent
US4122157A (en) * 1977-03-04 1978-10-24 Richardson-Merrell Inc. Nitrofurantoin sustained release tablet
GB1576376A (en) * 1977-03-30 1980-10-08 Benzon As Alfred Multiple-unit drug dose
FR2403080A1 (fr) * 1977-09-15 1979-04-13 Heyden Chem Fab Preparation de nitrofurantoine a effet retard pour administration orale et son procede de fabrication

Also Published As

Publication number Publication date
IL66961A (en) 1986-02-28
NO823534L (no) 1983-04-27
EP0078079A3 (en) 1983-06-29
PT75731B (en) 1985-06-28
AU8965182A (en) 1983-05-05
NO157805B (no) 1988-02-15
EP0078079A2 (en) 1983-05-04
JPS5883618A (ja) 1983-05-19
AT387142B (de) 1988-12-12
ES8400871A1 (es) 1983-12-01
ATA390382A (de) 1988-05-15
CA1181695A (en) 1985-01-29
DE3276522D1 (en) 1987-07-16
PT75731A (en) 1982-11-01
EP0078079B1 (en) 1987-06-10
IE822454L (en) 1983-04-26
DK472182A (da) 1983-04-27
ES516815A0 (es) 1983-12-01
AU557553B2 (en) 1986-12-24
JPS6241646B2 (pt) 1987-09-03
IL66961A0 (en) 1983-02-23
GR77686B (pt) 1984-09-25
IE54083B1 (en) 1989-06-07
NO157805C (no) 1988-05-25
US4370313A (en) 1983-01-25
ZA827457B (en) 1984-05-30
NZ202140A (en) 1985-12-13
PH17286A (en) 1984-07-06
FI823624A0 (fi) 1982-10-25

Similar Documents

Publication Publication Date Title
FI822759A0 (fi) Foerbindning av ett konstruktionsorgan
FI820766A0 (fi) Foerfarande foer framstaellning av ett vaermeisolerat ledningsroer
FI65915B (fi) Ledanordning foer ett benskydd
FI844540L (fi) Foerfarande foer framstaellning av ett antidiuretiskt preparat.
FI813238L (fi) Framstaellning av ett flexibelt repartat stycke
FI823208L (fi) Av ett isoleringsmaterial, saerskilt av mineralfibrer tillverkad platta
FI823624A0 (fi) Foerfarande foer framstaellning av ett preparat foer behandling av urinvaegsinfektioner
FI823986A0 (fi) Internt stoed foer hindrande av tillplattning av ett daeck
FI822987A0 (fi) Process foer tillverkning av ett alkalisalt av karboximetylcellulosaeter
FI832048L (fi) Faestande av stela insatser i ett elastiskt material
FI803951L (fi) Anordning foer rengoering av ett transportband
FI832116L (fi) Dekoder foer mottagning av ett oeverfoert meddelande
FI820685L (fi) Anordning foer aotdragning, av ett omlindningsband
FI800637A (fi) Foerfarande foer tillverkning av ett plastkaerl
FI820491L (fi) Foerfarande foer framstaellning av ett taendbraensle stroeningstekniskt foer en taendlaoga foer ett braennstoft av en existerande huvudbraenslestroem
FI824410L (fi) Anordning foer centrisk infoering av byggstoed i ett jordborrhaol
FI812485L (fi) Foerfarande foer framstaellning av ett kationiskt polymert flockningsmedel av akrylamidtyp
FI804020L (fi) Anordning foer styrning av ett fartyg
FI812851L (fi) Styranordning foer ett braennskaerarmunstycke
FI830782A0 (fi) Foerfarande foer framstaellning av ett insulinderivat
FI823357L (fi) Av ett aemne framstaellbar ask
FI823445L (fi) Foerfarande foer framstaellning av ett nytt isopropylaminopyrimidinderivat
FI813626L (fi) Foerfarande jaemte anordning foer aostadkommande av genombrytning av ett sandwichelement
FI821778A0 (fi) Kopplingsanordning foer inkoppling av ett elektronisk tonanrop i en tvaovaegs telefonstation
FI810949L (fi) Foerfarande foer bearbetning av ett arbetsstycke medelst ett eggfoersett rotationsverktyg

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: NORWICH EATON PHARMACEUTICALS, INC.